AbbVie to acquire Apogee Therapeutics in merger agreement dated June 18, 2026
AbbVie Inc. has entered into a definitive merger agreement to acquire Apogee Therapeutics, Inc. through a subsidiary merger structure. The transaction expands AbbVie's therapeutic pipeline and represents a significant M&A activity in the pharmaceutical sector.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day